Journal article
Stem Cell Ophthalmology Treatment Study: Bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION)
Stem Cell Investigation, Vol.4(11), pp.94-94
2017
DOI: 10.21037/sci.2017.11.05
PMCID: PMC5723737
PMID: 29270420
Abstract
Ten patients with bilateral visual loss due to sequential non-arteritic ischemic optic neuropathy (NAION) underwent autologous Bone Marrow Derived Stem Cell (BMSC) therapy within the Stem Cell Ophthalmology Treatment Study (SCOTS). SCOTS is an Institutional Review Board approved clinical study utilizing autologous BMSC in the treatment of optic nerve and retinal diseases that meet inclusion criteria.
Details
- Title: Subtitle
- Stem Cell Ophthalmology Treatment Study: Bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION)
- Creators
- Jeffrey N WeissSteven LevySusan C Benes
- Resource Type
- Journal article
- Publication Details
- Stem Cell Investigation, Vol.4(11), pp.94-94
- DOI
- 10.21037/sci.2017.11.05
- PMID
- 29270420
- PMCID
- PMC5723737
- NLM abbreviation
- Stem Cell Investig
- ISSN
- 2306-9759
- eISSN
- 2313-0792
- Language
- English
- Date published
- 2017
- Academic Unit
- Preventive and Community Dentistry; Epidemiology
- Record Identifier
- 9983917666802771
Metrics
81 Record Views